PRENTICE WEALTH MANAGEMENT LLC Neurocrine Biosciences, Inc. Transaction History

PRENTICE WEALTH MANAGEMENT LLC portfolio value:

$0
portfolio value

PRENTICE WEALTH MANAGEMENT LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -81 shares -8K $106.21 0
Q2 2022 share Decrease -51.50% -86 shares -8K $97.48 81
Q3 2021 share Decrease -23.39% -51 shares -5K $95.91 167
Q2 2021 share Decrease -3.54% -8 shares -1K $97.32 218
Q1 2021 share Increase 0.00% 226 shares 22K $97.25 226